Literature DB >> 1764264

Functional characterization of the human basic fibroblast growth factor gene promoter.

F Shibata1, A Baird, R Z Florkiewicz.   

Abstract

In order to understand the regulation of basic fibroblast growth factor (bFGF) gene expression, we have cloned and characterized the human bFGF gene and its regulatory elements. Using restriction endonuclease digestion, we have mapped the entire gene and sequenced all intron/exon boundaries to confirm authenticity and to determine organization. The data show that intron 1 is at least 16 kb long while intron 2 is 16 kb long. The human bFGF gene, including its three exons, is therefore at least 36 kb long. There are five GC boxes which may represent SP-1 binding sites and one potential AP-1 binding site within the core promoter region. Primer extension analysis indicates the presence of one bFGF-RNA transcription start site. We used a standard bacterial CAT gene expression system to identify the DNA sequence containing the functional bFGF gene promoter. Deletion analysis suggests the presence of two negative regulatory elements; one in the non-transcribed 5'-promoter region and the other within transcribed (but non-translated) sequences 3' of the promoter core.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1764264     DOI: 10.3109/08977199109043913

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  22 in total

1.  Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway.

Authors:  Y J Le; P M Corry
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy.

Authors:  Y Watanabe; R S Johnson; L S Butler; D K Binder; B M Spiegelman; V E Papaioannou; J O McNamara
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

3.  A dyad symmetry element in the fibroblast growth factor-2 gene promoter with different levels of activity in astrocytoma and hepatocelluar carcinoma cell lines.

Authors:  Tetsuya Ueba; Hisae Mori; Jun A Takahashi; Kazuhiko Nozaki; Nobuo Hashimoto
Journal:  J Neurooncol       Date:  2006-05-13       Impact factor: 4.130

4.  Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis.

Authors:  S Yoshida; M Ono; T Shono; H Izumi; T Ishibashi; H Suzuki; M Kuwano
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 5.  Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis.

Authors:  Chen Huang; Keping Xie
Journal:  Cytokine Growth Factor Rev       Date:  2012-02-16       Impact factor: 7.638

6.  An A/G-rich motif in the rat fibroblast growth factor-2 gene confers enhancer activity on a heterologous promoter in neonatal rat cardiac myocytes.

Authors:  K A Detillieux; A F Meyers; J T Meij; P A Cattini
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

7.  Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells.

Authors:  T Ueba; T Nosaka; J A Takahashi; F Shibata; R Z Florkiewicz; B Vogelstein; Y Oda; H Kikuchi; M Hatanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 8.  The fibroblast growth factor family: neuromodulation of affective behavior.

Authors:  Cortney A Turner; Stanley J Watson; Huda Akil
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Interleukin-1β enhances cell migration through AP-1 and NF-κB pathway-dependent FGF2 expression in human corneal endothelial cells.

Authors:  Jeong Goo Lee; Martin Heur
Journal:  Biol Cell       Date:  2013-03-07       Impact factor: 4.458

10.  Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.

Authors:  Rodrigo R Resende; Avishek Adhikari
Journal:  Cell Commun Signal       Date:  2009-08-27       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.